Comments
Loading...

C4 Therapeutics

CCCCNASDAQ
Logo brought to you by Benzinga Data
$4.31
-0.41-8.69%
At close: -
$4.45
0.143.25%
After Hours: 7:19 PM EDT

C4 Therapeutics (NASDAQ:CCCC) Stock Quotes, Forecast and News Summary

C4 Therapeutics Stock (NASDAQ: CCCC) stock price, news, charts, stock research, profile.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.7
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$4.77
Close$4.31
Volume / Avg.1.51M / 985.42K
Day Range$4.25 - $4.93
52 Wk Range1.06 - 11.88
Market Cap$314.12M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
30
Short Interest
10.05%
Days to Cover10.52

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CCCC
VALN

FAQ

Q

How do I buy C4 Therapeutics (CCCC) stock?

A

You can purchase shares of C4 Therapeutics (NASDAQ:CCCC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are C4 Therapeutics (CCCC) competitors?

Q

What is the forecast, or price target, for C4 Therapeutics (CCCC) stock?

A

C4 Therapeutics has a consensus price target of $11.10.

Q

What is the current price for C4 Therapeutics (CCCC)?

A

The stock price for C4 Therapeutics (NASDAQ: CCCC) is $4.45 last updated November 15, 2024 at 7:19 PM EST.

Q

Does C4 Therapeutics (CCCC) pay a dividend?

A

There are no upcoming dividends for C4 Therapeutics.

Q

When is C4 Therapeutics (NASDAQ:CCCC) reporting earnings?

A

C4 Therapeutics’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Q

Is C4 Therapeutics (CCCC) going to split?

A

There is no upcoming split for C4 Therapeutics.

Q

What sector and industry does C4 Therapeutics (CCCC) operate in?

A

C4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch